Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Michael X Fu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Occult hepatitis B (HBV) infection (OBI), characterized by low viral loads, accounts for much of the risk of HBV transfusion‐transmitted infection. With anticore antibodies (anti‐HBc) screening introduced in England, the imperative to identify OBI donors has increased. We aimed to develop an ultra‐sensitive PCR system and investigate risk factors for HBV DNA presence in blood donations. Seven extraction methods and three PCR assays were compared. The optimal system was sought to determine HBV DNA presence in anti‐HBc‐positive donations. Predictors of DNA positivity were subsequently investigated. Extraction from 5 mL of plasma increased sample representation and resulted in HBV DNA detection in low viral load samples (~0.5 IU/mL). Screening of 487 763 donations in 2022 identified two OBI donors and 2042 anti‐HBc‐positive donors, 412 of the latter with anti‐HBs < 100 mIU/mL. Testing of 134 anti‐HBc‐positive donations utilizing the 5 mL extraction method identified two further HBV DNA‐positive donations. Higher anti‐HBc titer and anti‐HBs negativity were significant predictors of DNA detectability in anti‐HBc‐positive donations. An ultrasensitive PCR assay identified potentially infectious donations increasing HBV DNA detection in anti‐HBc‐positive donors from 0.5% to 1.9%. Anti‐HBc titers may further complement the risk stratification for DNA positivity in anti‐HBc screening and minimize unnecessary donor deferral.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.
- Microbiology Services, NHS Blood and Transplant, Colindale, UK.
- Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- Division of Infection and Immunity, University College London, London, UK.
- Virus Reference Department, Blood Borne Virus Unit, UK Health Security Agency, London, UK.
ORCID-Profile: Michael X Fu, Peter Simmonds
Zitieren
APA
Fu, M. X., Simmonds, P., Andreani, J., Baklan, H., Webster, M., Asadi, R., Golubchik, T., Breuer, J., Ijaz, S., Ushiro-Lumb, I., Brailsford, S., Irving, W. L., Andersson, M., & Harvala, H. (2023). Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors. Journal of Medical Virology. https://doi.org/10.1002/jmv.29144
Vancouver
Fu MX, Simmonds P, Andreani J, Baklan H, Webster M, Asadi R, et al. Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors. Journal of Medical Virology. 2023. doi:10.1002/jmv.29144
BibTeX
@article{Fu2023,
author = {Fu, Michael X and Simmonds, Peter and Andreani, Julien and Baklan, Hatice and Webster, Mhairi and Asadi, Romisa and Golubchik, Tanya and Breuer, Judith and Ijaz, Samreen and Ushiro-Lumb, Ines and Brailsford, Su and Irving, William L and Andersson, Monique and Harvala, Heli},
title = {Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29144}
}
EUVIMED